The results of the UALCAN database showed that the expression of the hub genes TSR1, HSP90AA1, and NOP56 increased gradually with the advancing clinical stage of DLBCL patients, but there was no statistical significance (P > 0.05). The gene discussed is HSP90AA1; the disease is diffuse large B-cell lymphoma.